Modeling inter-sex and inter-individual variability in response to chronopharmacological administration of synthetic glucocorticoids

References

• Aerni A, Traber R, Hock C, Roozendaal B, Schelling G, Papassotiropoulos A, Nitsch RM, Schnyder U, de Quervain DJ. 2004. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry. 161:1488–1490.
   PubMed Web of Science ®Google Scholar
• Altemus M, Redwine L, Leong YM, Yoshikawa T, Yehuda R, Detera-Wadleigh S, Murphy DL. 1997. Reduced sensitivity to glucocorticoid feedback and reduced glucocorticoid receptor mRNA expression in the luteal phase of the menstrual cycle. Neuropsychopharmacology. 17:100–109.
   PubMed Web of Science ®Google Scholar
• Alten R, Doring G, Cutolo M, Gromnica-Ihle E, Witte S, Straub R, Buttgereit F. 2010. Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone. J Rheumatol. 37:2025–2031.
   PubMed Web of Science ®Google Scholar
• Alten R, Wiebe E. 2015. Hypothalamic-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with different glucocorticoid approaches. Neuroimmunomodulation. 22:83–88.
   PubMed Web of Science ®Google Scholar
• Arlt W, Stewart PM. 2005. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol Metab Clin North Am. ( viii) 34:293–313. doi:10.1016/j.ecl.2005.01.002.
   PubMed Web of Science ®Google Scholar
• Beltrametti SP, Ianniello A, Ricci C. 2016. Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review. Ther Clin Risk Manag. 12:1763–1776.
   PubMed Web of Science ®Google Scholar
• Buttgereit F, Burmester GR, Lipworth BJ. 2005. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet. 365:801–803.
   PubMed Web of Science ®Google Scholar
• Chrousos GP. 2010. Stress and sex versus immunity and inflammation. Sci Signal. 3:pe36.
   PubMed Web of Science ®Google Scholar
• Crown A, Lightman S. 2005. Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf). 63:483–492.
   PubMed Web of Science ®Google Scholar
• Cutolo M. 2016. Glucocorticoids and chronotherapy in rheumatoid arthritis. RMD Open. 2:e000203.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B. 2005. Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease’s symptoms. Autoimmun Rev. 4:497–502.
   PubMed Web of Science ®Google Scholar
• Czock D, Keller F, Rasche FM, Haussler U. 2005. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 44:61–98.
   PubMed Web of Science ®Google Scholar
• de Kloet ER. 2014. From receptor balance to rational glucocorticoid therapy. Endocrinology. 155:2754–2769.
   PubMed Web of Science ®Google Scholar
• de Quervain DJ, Margraf J. 2008. Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: a novel therapeutic approach. Eur J Pharmacol. 583:365–371.
   PubMed Web of Science ®Google Scholar
• Ebner K, Singewald N. 2017. Individual differences in stress susceptibility and stress inhibitory mechanisms. Cur Opin Behavioral Sci. 14:54–64.
   Web of Science ®Google Scholar
• Fardet L, Feve B. 2014. Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events. Drugs. 74:1731–1745.
   PubMed Web of Science ®Google Scholar
• Fietta P, Delsante G. 2009. Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry Clin Neurosci. 63:613–622.
   PubMed Web of Science ®Google Scholar
• Fisher LE, Ludwig EA, Wald JA, Sloan RR, Middleton E Jr., Jusko WJ. 1992. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm. Clin Pharmacol Ther. 51:677–688.
   PubMed Web of Science ®Google Scholar
• Gonder-Frederick LA, Grabman JH, Kovatchev B, Brown SA, Patek S, Basu A, Pinsker JE, Kudva YC, Wakeman CA, Dassau E, et al. 2016. Is psychological stress a factor for incorporation into future closed-loop systems? J Diabetes Sci Technol. 10:640–646.
   PubMedGoogle Scholar
• Griffin GD, Charron D, Al-Daccak R. 2014. Post-traumatic stress disorder: revisiting adrenergics, glucocorticoids, immune system effects and homeostasis. Clin Transl Immunology. 3:e27.
   PubMedGoogle Scholar
• Hartmanshenn C, Scherholz M, Androulakis IP. 2016. Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine. J Pharmacokinet Pharmacodyn. 43:481–504.
   PubMed Web of Science ®Google Scholar
• Haus E, Sackett-Lundeen L, Smolensky MH. 2012. Rheumatoid arthritis: circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications. Bull NYU Hosp Jt Dis. 70(Suppl 1):3–10.
   PubMedGoogle Scholar
• Jung CM, Khalsa SB, Scheer FA, Cajochen C, Lockley SW, Czeisler CA, Wright KP Jr. 2010. Acute effects of bright light exposure on cortisol levels. J Biol Rhythms. 25:208–216.
   PubMed Web of Science ®Google Scholar
• Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM. 2006. Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology (Berl). 189:225–235.
   PubMed Web of Science ®Google Scholar
• Juster RP, McEwen BS, Lupien SJ. 2010. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 35:2–16.
   PubMed Web of Science ®Google Scholar
• Kalsbeek A, Fliers E, Hofman MA, Swaab DF, Buijs RM. 2010. Vasopressin and the output of the hypothalamic biological clock. J Neuroendocrinol. 22:362–372.
   PubMed Web of Science ®Google Scholar
• Kalsbeek A, Verhagen LA, Schalij I, Foppen E, Saboureau M, Bothorel B, Buijs RM, Pevet P. 2008. Opposite actions of hypothalamic vasopressin on circadian corticosterone rhythm in nocturnal versus diurnal species. Eur J Neurosci. 27:818–827.
   PubMed Web of Science ®Google Scholar
• Karatsoreos IN, McEwen BS. 2011. Psychobiological allostasis: resistance, resilience and vulnerability. Trends Cogn Sci. 15:576–584.
   PubMed Web of Science ®Google Scholar
• Konstandi M. 2013. Psychophysiological stress: a significant parameter in drug pharmacokinetics. Expert Opin Drug Metab Toxicol. 9:1317–1334.
   PubMed Web of Science ®Google Scholar
• Kouri V-P, Olkkonen J, Kaivosoja E, Ainola M, Juhila J, Hovatta I, Konttinen YT, Mandelin J. 2013. Circadian timekeeping is disturbed in rheumatoid arthritis at molecular level. PLoS ONE. 8(1):e54049.
   Google Scholar
• Lew KH, Ludwig EA, Milad MA, Donovan K, Middleton E Jr., Ferry JJ, Jusko WJ. 1993. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 54:402–414.
   PubMed Web of Science ®Google Scholar
• Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H. 2013. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 9:30.
   PubMed Web of Science ®Google Scholar
• Magee MH, Blum RA, Lates CD, Jusko WJ. 2001. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. J Clin Pharmacol. 41:1180–1194.
   PubMed Web of Science ®Google Scholar
• McEwen BS, Kalia M. 2010. The role of corticosteroids and stress in chronic pain conditions. Metabolism. 59(Suppl 1):S9–15.
   PubMedGoogle Scholar
• Nicolaides NC, Charmandari E, Kino T, Chrousos GP. 2017. Stress-related and circadian secretion and target tissue actions of glucocorticoids: impact on health. Front Endocrinol (Lausanne). 8:70.
   PubMed Web of Science ®Google Scholar
• Oster H, Challet E, Ott V, Arvat E, Ronald de Kloet E, Dijk DJ, Lightman S, Vgontzas A, Van CE. 2017. The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids. Endocr Rev. 38:3–45.
   PubMed Web of Science ®Google Scholar
• Peng HT, Cheung B. 2011. A review of psychophysiological stressors on pharmacokinetics. J Clinical Pharmacology. 51:1499–1518.
   PubMed Web of Science ®Google Scholar
• Raglan GB, Schmidt LA, Schulkin J. 2017. The role of glucocorticoids and corticotropin-releasing hormone regulation on anxiety symptoms and response to treatment. Endocr Connect. 6:R1–R7.
   PubMed Web of Science ®Google Scholar
• Rao R, Androulakis IP. 2019. The physiological significance of the circadian dynamics of the HPA axis: Interplay between circadian rhythms, allostasis and stress resilience. Horm Behav. 110:77–89.
   PubMed Web of Science ®Google Scholar
• Rao RT, Androulakis IP. 2017a. Modeling the sex differences and inter-individual variability in the activity of the hypothalamic-pituitary-adrenal axis. Endocrinology. 158(11):4017–4037.
   Google Scholar
• Rao RT, Androulakis IP. 2017b. Modeling the sex differences and interindividual variability in the activity of the hypothalamic-pituitary-adrenal axis. Endocrinology. 158:4017–4037.
   PubMed Web of Science ®Google Scholar
• Rao RT, Scherholz ML, Androulakis IP. 2018. Modeling the influence of chronopharmacological administration of synthetic glucocorticoids on the hypothalamic-pituitary-adrenal axis. Chronobiol Int. 35(10):1619–1636.
   Google Scholar
• Ravindran V, Choy E. 2016. Modified-release prednisone in rheumatoid arthritis: Rationale for chronotherapy, mechanistic considerations, and clinical implications. Ind J Rheumatology. 11:216.
   Google Scholar
• Smith SM, Vale WW. 2006. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci. 8:383–395.
   PubMedGoogle Scholar
• Spiga F, Walker JJ, Terry JR, Lightman SL. 2014. HPA Axis-Rhythms. In: Terjung R, editor. Comprehensive Physiology. Hoboken (NJ, USA): John Wiley & Sons, Inc; p. 1273–1298.
   Google Scholar
• Sriram K, Rodriguez-Fernandez M, Doyle FJ 3rd. 2012. Modeling cortisol dynamics in the neuro-endocrine axis distinguishes normal, depression, and post-traumatic stress disorder (PTSD) in humans. PLoS Comput Biol. 8:e1002379.
   PubMed Web of Science ®Google Scholar
• Weiser MJ, Handa RJ. 2009. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience. 159:883–895.
   PubMed Web of Science ®Google Scholar
• Yehuda R, Halligan SL, Grossman R, Golier JA, Wong C. 2002. The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biol Psychiatry. 52:393–403.
   PubMed Web of Science ®Google Scholar
• Yehuda R, LeDoux J. 2007. Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron. 56:19–32.
   PubMed Web of Science ®Google Scholar
• Yehuda R, Seckl J. 2011. Minireview: Stress-related psychiatric disorders with low cortisol levels: a metabolic hypothesis. Endocrinology. 152:4496–4503.
   PubMed Web of Science ®Google Scholar
• Yehuda R, Southwick SM, Nussbaum G, Wahby V, Giller EL Jr., Mason JW. 1990. Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis. 178:366–369.
   PubMed Web of Science ®Google Scholar